BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 3071810)

  • 1. The role of peroxisomes in glycerol ether lipid metabolism.
    Hajra AK; Horie S; Webber KO
    Prog Clin Biol Res; 1988; 282():99-116. PubMed ID: 3071810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberration in de novo ether lipid biosynthesis in peroxisomal disorders.
    van den Bosch H; Schalkwijk CG; Schrakamp G; Wanders RJ; Schutgens RB; Schram AW; Tager JM
    Prog Clin Biol Res; 1988; 282():139-50. PubMed ID: 3071794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deficiency of enzymes catalyzing the biosynthesis of glycerol-ether lipids in Zellweger syndrome. A new category of metabolic disease involving the absence of peroxisomes.
    Datta NS; Wilson GN; Hajra AK
    N Engl J Med; 1984 Oct; 311(17):1080-3. PubMed ID: 6566965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The contribution of peroxisomes to lipid metabolism].
    Kramar R
    J Clin Chem Clin Biochem; 1986 Feb; 24(2):109-18. PubMed ID: 3711795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Peroxisomes and neurologic diseases].
    Sereni C; Paturneau-Jouas M
    Rev Neurol (Paris); 1989; 145(5):341-9. PubMed ID: 2472665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic relationship between the Zellweger syndrome and other peroxisomal disorders characterized by an impairment in the assembly of peroxisomes.
    Tager JM; Brul S; Wiemer EA; Strijland A; Van Driel R; Schutgens RB; Van den Bosch H; Wanders RJ; Westerveld A
    Prog Clin Biol Res; 1990; 321():545-58. PubMed ID: 2183242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmalogen biosynthesis in peroxisomal disorders: fatty alcohol versus alkylglycerol precursors.
    Schrakamp G; Schalkwijk CG; Schutgens RB; Wanders RJ; Tager JM; van den Bosch H
    J Lipid Res; 1988 Mar; 29(3):325-34. PubMed ID: 3379344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxisomal fatty acid beta-oxidation in relation to the accumulation of very long chain fatty acids in cultured skin fibroblasts from patients with Zellweger syndrome and other peroxisomal disorders.
    Wanders RJ; van Roermund CW; van Wijland MJ; Schutgens RB; Heikoop J; van den Bosch H; Schram AW; Tager JM
    J Clin Invest; 1987 Dec; 80(6):1778-83. PubMed ID: 3680527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topography of ether phospholipid biosynthesis.
    Hardeman D; van den Bosch H
    Biochim Biophys Acta; 1989 Nov; 1006(1):1-8. PubMed ID: 2804060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisomal disorders: clinical commentary and future prospects.
    Wilson GN; Holmes RD; Hajra AK
    Am J Med Genet; 1988 Jul; 30(3):771-92. PubMed ID: 2461077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New insights in peroxisomal beta-oxidation. Implications for human peroxisomal disorders.
    Van Veldhoven PP
    Verh K Acad Geneeskd Belg; 1998; 60(3):195-214. PubMed ID: 9803880
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biogenesis of peroxisomes in fetal liver.
    Espeel M; Depreter M; Nardacci R; D'Herde K; Kerckaert I; Stefanini S; Roels F
    Microsc Res Tech; 1997 Dec; 39(5):453-66. PubMed ID: 9408912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glyceryl ethers in peroxisomal disease.
    Poulos A; Bankier A; Beckman K; Johnson D; Robertson EF; Sharp P; Sheffield L; Singh H; Usher S; Wise G
    Clin Genet; 1991 Jan; 39(1):13-25. PubMed ID: 1705185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathophysiology of peroxisomal beta-oxidation.
    Vamecq J; Draye JP
    Essays Biochem; 1989; 24():115-225. PubMed ID: 2676523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Peroxisomal beta-oxidation].
    Mannaerts GP; Van Veldhoven PP
    Verh K Acad Geneeskd Belg; 1993; 55(1):45-78. PubMed ID: 8480447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inherited disorders of fatty alcohol metabolism.
    Rizzo WB
    Mol Genet Metab; 1998 Oct; 65(2):63-73. PubMed ID: 9787098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisomes, lipid metabolism, and peroxisomal disorders.
    Wanders RJ
    Mol Genet Metab; 2004; 83(1-2):16-27. PubMed ID: 15464416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisomal disorders in neurology.
    Wanders RJ; Heymans HS; Schutgens RB; Barth PG; van den Bosch H; Tager JM
    J Neurol Sci; 1988 Dec; 88(1-3):1-39. PubMed ID: 3066850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential deficiency of mevalonate kinase and phosphomevalonate kinase in patients with distinct defects in peroxisome biogenesis: evidence for a major role of peroxisomes in cholesterol biosynthesis.
    Wanders RJ; Romeijn GJ
    Biochem Biophys Res Commun; 1998 Jun; 247(3):663-7. PubMed ID: 9647750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological analyses of alkyl-dihydroxyacetone-phosphate synthase in human peroxisomal disorders.
    Biermann J; Gootjes J; Humbel BM; Dansen TB; Wanders RJ; van den Bosch H
    Eur J Cell Biol; 1999 May; 78(5):339-48. PubMed ID: 10384985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.